Author Affiliations: Kaiser Permanente, San Diego, California (Dr Lovett); Department of Family and Preventive Medicine (Dr Lovett), and Anesthesiology, and San Diego Center for Patient Safety (Dr Liang) UCSD School of Medicine; and Institute of Health Law Studies, California Western School of Law (Dr Liang), San Diego.
Direct-to-consumer (DTC) genetic testing has generated much concern due to nonstandardized products, unproven utility, and potential harm from testing results.1 Recommendations indicate that genetic testing should be US Food and Drug Administration (FDA)–approved, supported by predictive value and outcomes research, and offered only through qualified health care professionals.1
Lovett KM, Liang BA. Direct-to-Consumer Cardiac Screening and Suspect Risk Evaluation. JAMA. 2011;305(24):2567-2568. doi:10.1001/jama.2011.865